{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:38:40Z","timestamp":1791959920959,"version":"4.3.4"},"reference-count":15,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1185\/030079905x38222","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T17:31:46Z","timestamp":1119979906000},"page":"503-507","source":"Crossref","is-referenced-by-count":31,"title":["Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study"],"prefix":"10.1185","volume":"21","author":[{"given":"Nobuyuki","family":"Shoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2005,4,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00044-5"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00108-3"},{"key":"CIT0003","first-page":"400","volume":"126","author":"Silver LH","year":"1998","journal-title":"Clinical efficacy and safety of brinzolamide (Azopt\u00ae), a new topical carbonic anhydrase inhibitor for primary open- angle glaucoma and ocular hypertension. Am J Ophthalmol"},{"key":"CIT0005","first-page":"S155\u2013S162","volume":"44","author":"Sall K","year":"2000","journal-title":"The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt\u00ae) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Surv Ophthalmol"},{"key":"CIT0006","first-page":"235","volume":"132","author":"Michaud JE","year":"2001","journal-title":"5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol"},{"key":"CIT0007","first-page":"S163\u2013S168","volume":"44","author":"Shin D","year":"2000","journal-title":"Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt\u00ae) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy. Surv Ophthalmol"},{"key":"CIT0008","first-page":"65","volume":"54","author":"Kitazawa Y","year":"2003","journal-title":"Folia Ophthalmol Jpn"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-199400340-00002"},{"key":"CIT0010","first-page":"1023","volume":"45","author":"Phase Kitazawa Y.","year":"1994","journal-title":"Folia Ophthalmol Jpn"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01418-6"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00531-5"},{"key":"CIT0014","first-page":"75","volume":"108","author":"Aoyama Y","year":"2004","journal-title":"Effects of various antiglaucoma eyedrops on human corneal epithelial cells. Nippon Ganka Gakkai Zasshi"},{"key":"CIT0015","first-page":"490","volume":"23","author":"Noecker RJ","year":"2004","journal-title":"Corneal and conjunctival change caused by commonly used glaucoma medications. Cornea"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00438-3"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90532-5"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079905X38222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T08:43:46Z","timestamp":1481618626000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079905X38222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4,3]]},"published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1185\/030079905X38222"],"URL":"https:\/\/doi.org\/10.1185\/030079905x38222","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}